Developer docs
API playgroundTry for free, no card

Search company profiles

Iaso Health

Full company profile

uuid00q9qwj

Namestring
Iaso Health
Legal namestring
Iaso Solutions
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Iaso Health (operating as Iaso Solutions) is a Dublin-based, privately held B2B healthtech SaaS company founded in 2025 that markets a data-driven platform for personalized mental-health treatment planning. The platform ingests each patient's genetic, biological, and psychological profile and outputs individualized treatment recommendations, targeting two specialized clinical verticals: psychedelic-assisted therapy (PAT) clinics and medical cannabis / endocannabinoid therapy facilities. Its product surface comprises a core Iaso Solutions platform plus integrated modules for Personalized Treatment Plans, PAT Therapy, Endocannabinoid System Therapy, Data-Driven Insights, and Ongoing Support and Monitoring, positioned as a seamless screening-to-prescription workflow.

The underlying technology is described as a recommendation engine and predictive analytics layer operating on structured patient data; no proprietary ML models, patents, research publications, or named AI talent are disclosed, and the platform exposes no public API or SDK. The company employs a sales-led, consultation-driven go-to-market, capturing leads via meeting request forms, intake forms, and online scheduling, with content marketing and LinkedIn serving as the primary top-of-funnel channels. Pricing is quote-based and not publicly disclosed, and the revenue model is characterized as recurring SaaS subscriptions to clinics and healthcare professionals.

Operationally, Iaso is at an early stage: headcount is 1–10, geographic footprint is limited to Leinster, Ireland, no customer logos or contracts are disclosed, no certifications or compliance frameworks (e.g., HIPAA/GDPR) are listed, and no management team is publicly identified. The company's recent engagement with Techstars (dated 2026-03-25) is the only disclosed institutional signal, indicating the company is likely at a pre-seed or seed stage preparing for initial commercialization.

Short descriptiontext

Iaso Health is a Dublin-based B2B SaaS platform founded in 2025 that analyzes patients' genetic, biological, and psychological profiles to generate personalized treatment plans for psychedelic-assisted therapy clinics and medical cannabis facilities. The early-stage company (1–10 employees) uses a sales-led, subscription-based model with no disclosed customers or pricing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mental health software, personalized treatment plans, psychedelic therapy platform, medical cannabis software, clinical decision support
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Outpatient Mental Health and Substance Abuse Centers621420
Product category
Mental Health Treatment Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

The company operates as a B2B healthtech platform providing software to healthcare professionals. Based on the platform description and service offerings (scheduling, intake forms, consultation), the revenue model appears to be subscription-based SaaS for healthcare clinics and professionals.

healthtech-solutions-6wxg.b12sites.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Iaso Solutions delivers a B2B SaaS platform that analyzes each patient's unique genetic, biological, and psychological profile to generate personalized mental health treatment plans. The platform is tailored for healthcare professionals, psychedelic-assisted therapy clinics, and medical cannabis facilities, providing a seamless workflow from patient screening through to prescription, supported by data-driven insights and ongoing patient monitoring.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Iaso Solutions is a unified B2B healthtech SaaS platform consisting of multiple integrated modules: the core Iaso Solutions platform analyzes genetic, biological, and psychological patient profiles; paired with Personalized Treatment Plans for tailored care; PAT Therapy and Psychedelic-Assisted Therapy modules for innovative mental health treatments; Endocannabinoid System Therapy Solutions and Medical Cannabis Therapy for cannabis-based treatments; Data-Driven Insights for analytics; and Ongoing Support and Monitoring for continuous patient care. Together these products provide a seamless journey from screening to prescription for mental health clinics.

Product and service3 records
1Iaso Solutions Platform
CategoryClinical decision support software
Description

The core B2B healthtech SaaS platform that analyzes patient genetic, biological, and psychological profiles to enable personalized mental health treatment planning for healthcare professionals, psychedelic-assisted therapy clinics, and medical cannabis facilities. The platform integrates screening, assessment, treatment planning, data-driven insights, and ongoing patient monitoring.

2Personalized Treatment Plans
CategoryPersonalized treatment planning
Description

Tailored healthcare solutions that analyze each patient's unique genetic, biological, and psychological profile to create individualized treatment plans for optimal therapeutic outcomes. Targeted at mental health clinicians and clinics.

3Endocannabinoid System Therapy Solutions
CategoryMedical cannabis treatment software
Description

Comprehensive software offering for medical cannabis clinics that analyzes individual patient profiles and optimizes cannabis treatment offerings to enhance patient outcomes with a holistic approach to mental health care. Targeted at medical cannabis facilities and endocannabinoid therapy clinics.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

B2B mental health benefits platform sold to employers and health plans. Comparable to Iaso in selling mental-health software solutions into enterprise buyers, though at vastly greater scale and broader scope.

TypeBroad incumbent
Description

Online therapy and psychiatry platform with B2B (employer, health plan) and B2C distribution. Comparable as a scaled mental health SaaS/telehealth provider overlapping in customer segments with Iaso.

TypeRegional player
Description

Clinical-stage psychedelic therapy company developing psilocybin treatment for depression. Comparable as a serious commercial player in the psychedelic therapy space where Iaso sells its clinic software; useful proxy for end-market traction.

TypeBroad incumbent
Description

Larger digital mental health platform offering telehealth, medication management and therapy. Comparable as a B2B/B2C mental health software provider operating at much greater scale than Iaso.

TypeBroad incumbent
Description

Enterprise mental health platform providing therapy, coaching and medication management to employer clients. Comparable go-to-market motion (B2B sales to enterprise buyers) and mental health focus.

TypeBroad incumbent
Description

Mental health platform combining consumer meditation (Headspace) and therapy (Ginger) sold B2B and DTC. Comparable in mental health focus and B2B SaaS distribution into employer and payer channels.

TypeDirect peer
Description

Digital therapeutics company delivering software-based mental health treatments (e.g., EndeavorRx, AKL-T01). Comparable to Iaso as a software-first, clinically-targeted mental health platform sold into care settings.

TypeDirect peer
Description

AI-driven conversational mental health platform offered to health systems and payers. Comparable as an AI-native mental health SaaS targeting clinical and enterprise buyers, similar in stack and channel to Iaso.

TypeRegional player
Description

Clinical-stage biopharma platform investing in psychedelic and mental health therapies. Comparable as a high-profile emerging player in psychedelic mental health where Iaso targets its clinic software.

TypeDirect peer
Description

Digital therapeutics company (Sleepio, Daylight) for anxiety, insomnia and depression, sold B2B to health plans, employers and clinics. Comparable to Iaso's B2B SaaS GTM into care providers for mental health conditions.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Iaso Health

Mental Health Treatment Softwarehealthtech-solutions-6wxg.b12sites.com

Iaso Health is a Dublin-based B2B SaaS platform founded in 2025 that analyzes patients' genetic, biological, and psychological profiles to generate personalized treatment plans for psychedelic-assisted therapy clinics and medical cannabis facilities. The early-stage company (1–10 employees) uses a sales-led, subscription-based model with no disclosed customers or pricing.

What Iaso Health does

Iaso Health (operating as Iaso Solutions) is a Dublin-based, privately held B2B healthtech SaaS company founded in 2025 that markets a data-driven platform for personalized mental-health treatment planning. The platform ingests each patient's genetic, biological, and psychological profile and outputs individualized treatment recommendations, targeting two specialized clinical verticals: psychedelic-assisted therapy (PAT) clinics and medical cannabis / endocannabinoid therapy facilities. Its product surface comprises a core Iaso Solutions platform plus integrated modules for Personalized Treatment Plans, PAT Therapy, Endocannabinoid System Therapy, Data-Driven Insights, and Ongoing Support and Monitoring, positioned as a seamless screening-to-prescription workflow.

The underlying technology is described as a recommendation engine and predictive analytics layer operating on structured patient data; no proprietary ML models, patents, research publications, or named AI talent are disclosed, and the platform exposes no public API or SDK. The company employs a sales-led, consultation-driven go-to-market, capturing leads via meeting request forms, intake forms, and online scheduling, with content marketing and LinkedIn serving as the primary top-of-funnel channels. Pricing is quote-based and not publicly disclosed, and the revenue model is characterized as recurring SaaS subscriptions to clinics and healthcare professionals.

Operationally, Iaso is at an early stage: headcount is 1–10, geographic footprint is limited to Leinster, Ireland, no customer logos or contracts are disclosed, no certifications or compliance frameworks (e.g., HIPAA/GDPR) are listed, and no management team is publicly identified. The company's recent engagement with Techstars (dated 2026-03-25) is the only disclosed institutional signal, indicating the company is likely at a pre-seed or seed stage preparing for initial commercialization.

Iaso Health firmographics

Firmographics
Name
Iaso Health
Legal name
Iaso Solutions
Website
https://healthtech-solutions-6wxg.b12sites.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Iaso Health is a Dublin-based B2B SaaS platform founded in 2025 that analyzes patients' genetic, biological, and psychological profiles to generate personalized treatment plans for psychedelic-assisted therapy clinics and medical cannabis facilities. The early-stage company (1–10 employees) uses a sales-led, subscription-based model with no disclosed customers or pricing.
Ownership category
akta.pro rank

Where Iaso Health is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

Iaso Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription: The company operates as a B2B healthtech platform providing software to healthcare professionals. Based on the platform description and service offerings (scheduling, intake forms, consultation), the revenue model appears to be subscription-based SaaS for healthcare clinics and professionals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Iaso Health product offering

Product offering

Core offering

Iaso Solutions delivers a B2B SaaS platform that analyzes each patient's unique genetic, biological, and psychological profile to generate personalized mental health treatment plans. The platform is tailored for healthcare professionals, psychedelic-assisted therapy clinics, and medical cannabis facilities, providing a seamless workflow from patient screening through to prescription, supported by data-driven insights and ongoing patient monitoring.

Product overview

Iaso Solutions is a unified B2B healthtech SaaS platform consisting of multiple integrated modules: the core Iaso Solutions platform analyzes genetic, biological, and psychological patient profiles; paired with Personalized Treatment Plans for tailored care; PAT Therapy and Psychedelic-Assisted Therapy modules for innovative mental health treatments; Endocannabinoid System Therapy Solutions and Medical Cannabis Therapy for cannabis-based treatments; Data-Driven Insights for analytics; and Ongoing Support and Monitoring for continuous patient care. Together these products provide a seamless journey from screening to prescription for mental health clinics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Iaso Solutions Platform The core B2B healthtech SaaS platform that analyzes patient genetic, biological, and psychological profiles to enable personalized mental health treatment planning for healthcare professionals, psychedelic-assisted therapy clinics, and medical cannabis facilities. The platform integrates screening, assessment, treatment planning, data-driven insights, and ongoing patient monitoring.
  • Personalized Treatment Plans Tailored healthcare solutions that analyze each patient's unique genetic, biological, and psychological profile to create individualized treatment plans for optimal therapeutic outcomes. Targeted at mental health clinicians and clinics.
  • Endocannabinoid System Therapy Solutions Comprehensive software offering for medical cannabis clinics that analyzes individual patient profiles and optimizes cannabis treatment offerings to enhance patient outcomes with a holistic approach to mental health care. Targeted at medical cannabis facilities and endocannabinoid therapy clinics.

Companies that use Iaso Health

Customer profile

Segments3 records

Ideal customer profiles3 records

Iaso Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Iaso Health partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Iaso Health competitors and assessment

Company assessment

Broad incumbents

  • Spring Health: B2B mental health benefits platform sold to employers and health plans. Comparable to Iaso in selling mental-health software solutions into enterprise buyers, though at vastly greater scale and broader scope.
  • Talkspace: Online therapy and psychiatry platform with B2B (employer, health plan) and B2C distribution. Comparable as a scaled mental health SaaS/telehealth provider overlapping in customer segments with Iaso.
  • Cerebral: Larger digital mental health platform offering telehealth, medication management and therapy. Comparable as a B2B/B2C mental health software provider operating at much greater scale than Iaso.
  • Lyra Health: Enterprise mental health platform providing therapy, coaching and medication management to employer clients. Comparable go-to-market motion (B2B sales to enterprise buyers) and mental health focus.
  • Headspace Health: Mental health platform combining consumer meditation (Headspace) and therapy (Ginger) sold B2B and DTC. Comparable in mental health focus and B2B SaaS distribution into employer and payer channels.

Regional players

  • Compass Pathways: Clinical-stage psychedelic therapy company developing psilocybin treatment for depression. Comparable as a serious commercial player in the psychedelic therapy space where Iaso sells its clinic software; useful proxy for end-market traction.
  • ATAI Life Sciences: Clinical-stage biopharma platform investing in psychedelic and mental health therapies. Comparable as a high-profile emerging player in psychedelic mental health where Iaso targets its clinic software.

Direct peers

  • Akili Interactive: Digital therapeutics company delivering software-based mental health treatments (e.g., EndeavorRx, AKL-T01). Comparable to Iaso as a software-first, clinically-targeted mental health platform sold into care settings.
  • Woebot Health: AI-driven conversational mental health platform offered to health systems and payers. Comparable as an AI-native mental health SaaS targeting clinical and enterprise buyers, similar in stack and channel to Iaso.
  • Big Health: Digital therapeutics company (Sleepio, Daylight) for anxiety, insomnia and depression, sold B2B to health plans, employers and clinics. Comparable to Iaso's B2B SaaS GTM into care providers for mental health conditions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Iaso Health social profiles

Digital presence

Iaso Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Iaso Health leadership team

Management profile

Number of profiles

Iaso Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Iaso Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iaso Health

What does Iaso Health do?

Iaso Solutions delivers a B2B SaaS platform that analyzes each patient's unique genetic, biological, and psychological profile to generate personalized mental health treatment plans. The platform is tailored for healthcare professionals, psychedelic-assisted therapy clinics, and medical cannabis facilities, providing a seamless workflow from patient screening through to prescription, supported by data-driven insights and ongoing patient monitoring.

Is Iaso Health a public or private company?

Iaso Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Iaso Health founded?

Iaso Health was founded in 2025. It employs 1 to 10 people.

Where is Iaso Health based?

Iaso Health is headquartered in Dublin, Ireland, in the Europe region.

How does Iaso Health make money?

One revenue line is on record: saaS Platform Subscription.

Who are Iaso Health's main competitors?

Broad incumbents on record are Spring Health, Talkspace, Cerebral, Lyra Health and Headspace Health. Regional players are Compass Pathways and ATAI Life Sciences. Direct peers are Akili Interactive, Woebot Health and Big Health.

Does Iaso Health have an API?

No public API is recorded for Iaso Health.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales